About the Authors
- Jan Vesterbacka
-
* E-mail: jan.vesterbacka@karolinska.se
Affiliation Unit of Infectious Diseases, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
- Piotr Nowak
-
Affiliations Unit of Infectious Diseases, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden, Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
- Babilonia Barqasho
-
Affiliation Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
- Samir Abdurahman
-
Affiliation Unit of Infectious Diseases, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
- Jessica Nyström
-
Affiliation Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
- Staffan Nilsson
-
Affiliation Department of Mathematical Statistics, Chalmers University of Technology, Gothenburg, Sweden
- Hiroyuki Funaoka
-
Affiliation DS Pharma Biomedical Company, Limited, Osaka, Japan
- Tatsuo Kanda
-
Affiliation Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Science, Niigata, Japan
- Lars-Magnus Andersson
-
Affiliation Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden
- Magnus Gisslèn
-
Affiliation Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden
- Anders Sönnerborg
-
Affiliations Unit of Infectious Diseases, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden, Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
Competing Interests
The authors do not have a commercial or other association that might pose a conflict of interest with the exception of Dr HF is employed by DS Pharma Biomedical Co., Ltd, the company that developed a kit for I-FABP. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: JV, PN, AS, HF, TK, L-MA, MG. Performed the experiments:. BB, SA, JN. Analyzed the data: JV, PN, AS. Wrote the paper: JV, PN, AS.